Medindia

X

Boston Scientific to Participate in Merrill Lynch Conference

Thursday, January 31, 2008 General News J E 4
Advertisement
NATICK, Mass., Jan. 30 Boston ScientificCorporation (NYSE: BSX) is scheduled to participate in the 2008 Merrill LynchGlobal Pharmaceutical, Biotechnology and Medical Device Conference, which isbeing held February 5-7 in New York City.

Paul LaViolette, Chief Operating Officer, will make a 40-minutepresentation on Wednesday, February 6, beginning at approximately 10:20 a.m.E.T. Sam Leno, Executive Vice President and Chief Financial Officer will joinMr. LaViolette in a question and answer session.

A live webcast of Mr. LaViolette's remarks and the question and answersession will be available to all interested parties at Boston Scientific'swebsite at www.bostonscientific.com. Please visit the website for details onhow to access the webcast. To ensure a timely connection to the webcast it isrecommended that users register at least 15 minutes before the webcast begins.

This webcast is being hosted by Merrill Lynch. The replay will bearchived and available in the Investor Relations site atwww.bostonscientific.com.

Boston Scientific is a worldwide developer, manufacturer and marketer ofmedical devices whose products are used in a broad range of interventionalmedical specialties. For more information, please visit:www.bostonscientific.com.CONTACT: Paul Donovan 508-650-8541 (office) 508-667-5165 (mobile) Media Relations Boston Scientific Corporation Dan Brennan 508-650-8538 (office) Investor Relations Boston Scientific Corporation

SOURCE Boston Scientific Corporation
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Pennsylvania Commission for Women Encourages Obser...
S
MichBio Responds to Governor's Plan to Repeal Tort...